Nomura Holdings’s Medicines Co MDCO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-129,170
Closed -$11M 1353
2019
Q4
$11M Buy
129,170
+74,170
+135% +$4.95M 0.04% 298
2019
Q3
$2.69M Buy
55,000
+4,926
+10% +$197K 0.01% 593
2019
Q2
$1.89M Buy
50,074
+44,830
+855% +$1.46M 0.01% 696
2019
Q1
$149K Buy
5,244
+5,144
+5,144% +$121K ﹤0.01% 1047
2018
Q4
$2K Hold
100
﹤0.01% 1161
2018
Q3
$3K Sell
100
-3,216
-97% -$121K ﹤0.01% 1255
2018
Q2
$122K Buy
3,316
+3,216
+3,216% +$105K ﹤0.01% 1202
2018
Q1
$3 Buy
+100
New +$3.13K ﹤0.01% 1397
2017
Q2
Sell
-100
Closed -$5K 1674
2017
Q1
$5K Sell
100
-7,579
-99% -$346K ﹤0.01% 1239
2016
Q4
$263K Buy
+7,679
New +$272K ﹤0.01% 1377
2016
Q2
Sell
-2,700
Closed -$86K 1758
2016
Q1
$86K Buy
+2,700
New +$88.2K ﹤0.01% 1409
2015
Q3
Sell
-100
Closed -$3K 2089
2015
Q2
$3K Buy
+100
New +$2.79K ﹤0.01% 1743
2014
Q4
Sell
-62,407
Closed -$1.4M 2886
2014
Q3
$1.4M Buy
62,407
+41,361
+197% +$1.05M ﹤0.01% 1283
2014
Q2
$611K Sell
21,046
-2,450
-10% -$65.4K ﹤0.01% 1670
2014
Q1
$667K Sell
23,496
-1,606
-6% -$53.1K ﹤0.01% 1641
2013
Q4
$969K Sell
25,102
-13,883
-36% -$496K ﹤0.01% 1005
2013
Q3
$1.3M Buy
+38,985
New +$1.24M 0.01% 979

Other funds holding MDCO

Nomura Holdings's MDCO Position: Q1 2020 in Review

Nomura Holdings sold out of Medicines Co (MDCO) in Q1 2020, closing a stake of 129,170 shares — an estimated $11M sold.

Nomura Holdings first reported a position in MDCO in Q3 2013 and held it in 17 quarters. The position peaked at $11M in Q4 2019. 1 fund tracked by Wall St. Rank holds MDCO as of Q1 2020.

  • Nomura Holdings reported no remaining Medicines Co position as of Q1 2020 after selling out during the quarter.
  • Nomura Holdings sold 129,170 Medicines Co shares in Q1 2020, an estimated $11M.
  • Nomura Holdings first reported a position in Medicines Co in Q3 2013 and held it in 17 quarters.
  • Nomura Holdings's Medicines Co position peaked at $11M in Q4 2019.
  • 1 fund tracked by Wall St. Rank held Medicines Co as of Q1 2020.

Based on Nomura Holdings's 13F filing for Q1 2020, filed 14 May 2020.